The Role of Robotic Surgery in Treating Hepatobiliary and Pancreatic Malignancies
Issued Date
2022-01-01
Resource Type
Scopus ID
2-s2.0-85153656186
Journal Title
Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century
Start Page
777
End Page
785
Rights Holder(s)
SCOPUS
Bibliographic Citation
Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century (2022) , 777-785
Suggested Citation
Yiengpruksawan A. The Role of Robotic Surgery in Treating Hepatobiliary and Pancreatic Malignancies. Hepato-Pancreato-Biliary Malignancies: Diagnosis and Treatment in the 21st Century (2022) , 777-785. 785. doi:10.1007/978-3-030-41683-6_45 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/86217
Title
The Role of Robotic Surgery in Treating Hepatobiliary and Pancreatic Malignancies
Author(s)
Author's Affiliation
Other Contributor(s)
Abstract
Background The advent of robotic surgery has promised to make minimally invasive surgery for pancreatic and hepatobiliary cancer accessible for surgeons who find the laparoscopic approach too challenging to master. This chapter explores the premise and discusses robotics’ evolution, current status, and future potentials in treating hepatobiliary and pancreatic cancer surgery through reviewed articles, industry published resources, and the literature related to robotic hepatobiliary and pancreatic surgery from January 2001 to December 2020. Result The unique advantages of the robotic surgical system help shorten the learning curve in complex hepatobiliary-pancreatic procedures, although at a higher financial cost than the traditional laparoscopic approach. Direct digital integration of new technologies into the robotic platform allows for unlimited potential applications and utilization of the system, especially in precision cancer surgery. Although the level of evidence was low, robotic hepatobiliary-pancreatic cancer surgery was statistically not inferior to the standard laparoscopic approach in both shortand long-term outcomes. Conclusion The role of robotics in treating hepatobiliary and pancreatic cancer continues to evolve and should be considered exploratory at the current stage.